step 3 Flashcards
What are the aims of step 3 treatment?
To treat areas not responding to step 2 with the purpose of gaining further access to subgingival instrumentation or aiming at regenerating or resecting the lesions that add complexity in periodontitis management (infrabony defects and furcation lesions)
Give 2 examples of local microbials
Disinfectants - chlorhexidine
Locally delivered antibiotics
What is a periochip?
A 2.5mg chlorhexidine digluconate biodegradable gelation matrix inserted into a pocket following PMPR
No significant differences in CAL
What is dentomycin periodontal gel?
2% minocycline gel
Syringe delivered into pocket following subgingival PMPR
3-4 applications every 14 days
Can lead to short term improvements in PPD and CAL
What is the BSP and SDCEP guidance on local antimicrobials?
May be considered as an adjunct to subgingival instrumentation
Not recommended for routine care and management for periodontitis patients
How do systemic antimicrobials work?
By suppressing the bacterial species responsible for biofilm growth, leading to a less pathogenic oral environment
What is the BSP and SDCEP guidance for using systemic antimicrobials?
Not recommended - don’t want antibiotic resistance
When should antibiotics be considered and how should they be given?
Periodontitis grade C in younger adults where a high rate of progression is documented
Full mouth instrumentation in a 24 hour period followed by 400mg metronidazole three times daily for 7 days
What is host modulation therapy?
Uses local or systemic drugs as adjuncts to conventional periodontal tx aiming to modify the destructive aspects of the host inflammatory response to the microbial biofilm
Uses a sub-antimicrobial dose of doxycycline
Name 4 other drugs used in host modulation therapy
Any from:
- statins
- bisphosphonates
- probiotics
- NSAIDs
- Omega-3 fatty acids
- metformin
When is periodontal surgery indicated?
In sites where good quality non-surgical periodontal tx has not resolved periodontal pocketing and there is ongoing inflammation/infection
In periodontal pocketing ≥6mm
In cases with suitable pt, tooth and defect factors:
- no medical contra-indications
- teeth of reasonable prognosis
- infrabony defects, furcation involvement
What pt factors should be considered in step 3?
OH - <20% plaque, <10% marginal bleeding
Quality of maintenance care available and pt access to it
Ability of pt to tolerate procedure
Likely pt compliance post surgery
Cost and pt acceptance
Aesthetics of the site and potential for post-op recession
What tooth factors should be considered in step 3?
Access to non-responding sites
Shape of defect
Prosthodontics/endodontic considerations
Tooth positioning/anatomy:
- tilting
- overeruption
- proximity to adjacent roots
- enamel pearls
- ridges/root grooves
What systemic/medical factors should be considered in step 3?
Smoking
Unstable angina, uncontrolled hypertension, MI/strokes within 6 months
Poorly controlled diabetes
Immunosuppressed pt
Anticoagulants - DOACs, warfarin, antiplatelets
What is included in the consent process in step 3?
Reason for providing tx
Other options for management, including no tx
Consequences of not providing surgery
Nature of surgical procedure
Post-op consequences - positive and negative
Requirement for ongoing post-op maintenance
Costs